Lexaria Bioscience Corp expected to post a loss of 15 cents a share - Earnings Preview

Lexaria Bioscience

04/04/2025 21:05

Lexaria Bioscience Corp LEXX.OQ LEXX.O is expected to report resultson April 7 (estimated) for the period ending February 28 2025

The Kelowna British Columbia-based  company is expected to report revenue of $137 thousand, according to the mean estimate from 2 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Lexaria Bioscience Corp is for a loss of 15 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Lexaria Bioscience Corp is $7.50​, above​ its last closing price of $1.53. ​​​

This summary was machine generated April 4 at 20:05 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)